02/12/2025
8:34 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
3:30 PM | Jacquet Pierre (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Jenkins Annalisa (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Mereo BioPharma Group (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Mereo BioPharma Group (Issuer)
Shames Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Ekblom Anders (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Bender Jeremy (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:30 PM | Mereo BioPharma Group (Issuer)
Yoskowitz Marc J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:07 PM | Mereo BioPharma Group (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
5:32 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MREO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mereo BioPharma Group and its competitors with MarketBeat's FREE daily newsletter. |
12/06/2024
10:37 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024
10:44 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G/A | |
11/12/2024
3:49 PM | Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A | |
09/16/2024
7:46 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:47 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:48 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:49 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:50 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:47 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:49 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:49 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:50 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:57 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:05 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
5:13 PM | Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:35 PM | Mereo BioPharma Group (Subject)
PAKIANATHAN DEEPIKA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:19 AM | Mereo BioPharma Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
7:09 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
10:46 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
06/27/2024
3:15 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:13 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:13 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
06/25/2024
5:14 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:21 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
5:53 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024
5:58 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144/A | |
06/24/2024
6:00 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024
6:04 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144/A | |
06/24/2024
6:04 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/20/2024
3:27 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:30 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:32 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:34 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:16 PM | Mereo BioPharma Group (Issuer)
Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
8:15 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2024
11:15 PM | Mereo BioPharma Group (Filer)
| Form EFFECT | |
05/23/2024
8:54 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:38 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:49 PM | Mereo BioPharma Group (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/15/2024
3:19 PM | Mereo BioPharma Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:36 AM | Mereo BioPharma Group (Filer)
| Form ARS | |
04/24/2024
6:30 AM | Mereo BioPharma Group (Filer)
| Form DEF 14A | |
04/16/2024
1:58 PM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
04/15/2024
6:30 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
4:20 PM | Mereo BioPharma Group (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
